Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Bristol Myers Squibb
Bristol Myers Squibb
C-Suite
Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent cliff’ plan
By
Diane Brady
December 5, 2025
Bristol-Myers Squibb (BMY) Q3 2025 Earnings Call Transcript
By
Fortune Editors
October 30, 2025
Bristol-Myers Squibb (BMY) Q2 2025 Earnings Call Transcript
By
Fortune Editors
July 31, 2025
Bristol-Myers Squibb (BMY) Q1 2025 Earnings Call Transcript
By
Fortune Editors
April 24, 2025
Health
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By
Lindsey Leake
February 7, 2025
Bristol-Myers Squibb (BMY) Q4 2024 Earnings Call Transcript
By
Fortune Editors
February 6, 2025
Health
20 innovative breakthroughs that will transform your health
By
Erika Fry
December 18, 2024
Commentary
Developing new medicines for everyone, everywhere, equally
By
Giovanni Caforio, MD
November 13, 2023
Newsletters
Here’s what differentiates the top 25 corporate boards from their counterparts
By
Lila MacLellan
May 12, 2023
Leadership
These 25 companies have the most ‘modern’ boards. Here’s what that means
By
Lila MacLellan
May 10, 2023
Newsletters
What a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.
By
Jeremy Kahn
and
Jonathan Vanian
January 25, 2022
Conferences
Leaders from Peloton, Chobani, and more on how brands earn their purpose
By
Lydia Belanger
October 13, 2021
Health
Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By
Sy Mukherjee
August 5, 2021
Tech
British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By
Jeremy Kahn
June 15, 2021
Health
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
By
Harris Meyer
and
Kaiser Health News
December 28, 2020
Most Popular
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist...
By
Kent Jones
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By
Preston Fore
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to...
By
Preston Fore